Author

Haiwei Gu

Primary ORCID profile (0000-0002-7598-5022 · 20 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Haiwei GuiD20 papers · Arizona State University

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Amanda P. Beck· 1 shared Barbora Vyhlídalová· 1 shared Hao Li· 1 shared Hillary Guzik· 1 shared Lucia Sládeková· 1 shared Sridhar ManiiD· 1 shared Vera M. DesMarais· 1 shared Zdenek DvořákiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Amanda P. Beck

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Unlocking the Potential: FKK6 as a Microbial Mimicry Based Therapy for Chronic Inflammation-Associated Colorectal Cancer in a Murine Model

Lucia Sládeková, Hao Li, Vera M. DesMarais, Amanda P. Beck, Hillary Guzik, Barbora Vyhlídalová, Haiwei Gu, Sridhar Mani, Zdenek Dvořák

This study evaluates FKK6, a microbial mimic of an indole metabolite, as a therapy for colitis-associated colorectal cancer in mice, showing anti-tumor effects and safety.

bioRxiv · Jul 30, 2024Pharmacology & Toxicology